| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Heart and Circulatory Physiology, Vol 265, Issue 2 586-H592, Copyright © 1993 by American Physiological Society
ARTICLES |
D. D. Ku, J. K. Zaleski, S. Liu and T. A. Brock
Department of Pharmacology, University of Alabama at Birmingham 35294.
Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF), has recently been shown to increase cytosolic free calcium in endothelial cells. In the present study, we investigated the coronary vascular effects of recombinant human and native guinea pig VEGF/VPF in isolated canine coronary arteries in the presence and absence of intimal endothelium, indomethacin, and NG-monomethyl-L-arginine, a competitive nitric oxide synthase inhibitor. Addition of recombinant VEGF/VPF (1-660 pM) in coronary arteries that had been previously contracted with prostaglandin F2 alpha induced a slow, dose-dependent relaxation, reaching a maximum of -59.1 +/- 6.7% (mean +/- SE, n = 19). Mechanical disruption of the intimal endothelium completely abolished the observed relaxation. No direct vascular effect of recombinant VEGF/VPF on the endothelium-disrupted coronary arteries was noted. Pretreatment of endothelium-intact coronary arteries with 5 microM of indomethacin did not alter the observed relaxation (-57.3 +/- 7.0%, n = 18), whereas pretreatment with either NG-monomethyl-L-arginine or 10 microM of genistein, a known inhibitor of tyrosine kinase, significantly inhibited the relaxation. Addition of native VEGF/VPF (1-100 pM) also induced an endothelium-dependent relaxation in the isolated coronary arteries. Heating of recombinant VEGF/VPF (70 degrees C, 25 min) or prior incubation with a specific antibody raised against a VEGF/VPF peptide completely abolished the relaxation. Finally, recombinant VEGF/VPF stimulated a slow rise in cytosolic free calcium in cultured human endothelial cells that was qualitatively similar to that of native VEGF/VPF.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  P. Bhargava VEGF kinase inhibitors: how do they cause hypertension? Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2009; 297(1): R1 - R5. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Jacobs, D. Zhu, S. Gruenloh, B. Lopez, and M. Medhora VEGF-induced relaxation of pulmonary arteries is mediated by endothelial cytochrome P-450 hydroxylase Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L369 - L377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-W. Cheng, A.F. James, R.R. Foster, J.C. Hancox, and D.O. Bates VEGF Activates Receptor-Operated Cation Channels in Human Microvascular Endothelial Cells Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1768 - 1776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. F. Voelkel, R. W. Vandivier, and R. M. Tuder Vascular endothelial growth factor in the lung Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L209 - L221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Vonnahme, M. E. Wilson, Y. Li, H. L. Rupnow, T. M. Phernetton, S. P. Ford, and R. R. Magness Circulating levels of nitric oxide and vascular endothelial growth factor throughout ovine pregnancy J. Physiol., May 15, 2005; 565(1): 101 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Foster, M. A. Saleem, P. W. Mathieson, D. O. Bates, and S. J. Harper Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes Am J Physiol Renal Physiol, January 1, 2005; 288(1): F48 - F57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hattan, D. Warltier, W. Gu, C. Kolz, W. M. Chilian, and D. Weihrauch Autologous vascular smooth muscle cell-based myocardial gene therapy to induce coronary collateral growth Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H488 - H493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ashrafpour, N. Huang, P. C. Neligan, C. R. Forrest, P. D. Addison, M. A. Moses, R. H. Levine, and C. Y. Pang Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H946 - H954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. O. Bates and R. O. P. Jones The Role of Vascular Endothelial Growth Factor in Wound Healing International Journal of Lower Extremity Wounds, June 1, 2003; 2(2): 107 - 120. [Abstract] [PDF]
|
|
|
|
 |
|
 D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kobayashi and K. Kamata Short-term insulin treatment and aortic expressions of IGF-1 receptor and VEGF mRNA in diabetic rats Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1761 - H1768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ando, A. Yang, H. Nambu, and P. A. Campochiaro Blockade of Nitric-Oxide Synthase Reduces Choroidal Neovascularization Mol. Pharmacol., September 1, 2002; 62(3): 539 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lin, J. LeCouter, J. Kowalski, and N. Ferrara Characterization of Endocrine Gland-derived Vascular Endothelial Growth Factor Signaling in Adrenal Cortex Capillary Endothelial Cells J. Biol. Chem., March 1, 2002; 277(10): 8724 - 8729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Marchand, N. Noiseux, J.-F. Tanguay, and M. G. Sirois Blockade of in vivo VEGF-mediated angiogenesis by antisense gene therapy: role of Flk-1 and Flt-1 receptors Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H194 - H204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rajagopalan, M. Shah, A. Luciano, R. Crystal, and E. G. Nabel Adenovirus-Mediated Gene Transfer of VEGF121 Improves Lower-Extremity Endothelial Function and Flow Reserve Circulation, August 14, 2001; 104(7): 753 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A.W. Broeders, P. A. Doevendans, J. G. Maessen, E. van Gorsel, M. G.A. O. Egbrink, M. J. A.P. Daemen, G. J. Tangelder, R. S. Reneman, and R. van der Zee The human internal thoracic artery releases more nitric oxide in response to vascular endothelial growth factor than the human saphenous vein J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 305 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Epstein, R. Kornowski, S. Fuchs, and H. F. Dvorak Angiogenesis Therapy : Amidst the Hype, the Neglected Potential for Serious Side Effects Circulation, July 3, 2001; 104(1): 115 - 119. [Full Text] [PDF]
|
|
|
|
 |
|
 I. Zachary Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor Am J Physiol Cell Physiol, June 1, 2001; 280(6): C1375 - C1386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kuzuya, M. A. Ramos, S. Kanda, T. Koike, T. Asai, K. Maeda, K. Shitara, M. Shibuya, and A. Iguchi VEGF Protects Against Oxidized LDL Toxicity to Endothelial Cells by an Intracellular Glutathione-Dependent Mechanism Through the KDR Receptor Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 765 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. T. Yang, Z. Yan, J. A. Abraham, and R. L. Terjung VEGF121- and bFGF-induced increase in collateral blood flow requires normal nitric oxide production Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1097 - H1104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Partovian, S. Adnot, B. Raffestin, V. Louzier, M. Levame, I. M. Mavier, P. Lemarchand, and S. Eddahibi Adenovirus-Mediated Lung Vascular Endothelial Growth Factor Overexpression Protects against Hypoxic Pulmonary Hypertension in Rats Am. J. Respir. Cell Mol. Biol., December 1, 2000; 23(6): 762 - 771. [Abstract] [Full Text]
|
|
|
|
|
|
T. M. Pocock, B. Williams, F. E. Curry, and D. O. Bates VEGF and ATP act by different mechanisms to increase microvascular permeability and endothelial [Ca2+]i Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1625 - H1634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Zachary, A. Mathur, S. Yla-Herttuala, and J. Martin Vascular Protection : A Novel Nonangiogenic Cardiovascular Role for Vascular Endothelial Growth Factor Arterioscler Thromb Vasc Biol, June 1, 2000; 20(6): 1512 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Vidal, J. Aragones, A. Alfranca, and M. O. de Landazuri Up-regulation of vascular endothelial growth factor receptor Flt-1 after endothelial denudation: role of transcription factor Egr-1 Blood, June 1, 2000; 95(11): 3387 - 3395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. He, V. J. Venema, X. Gu, R. C. Venema, M. B. Marrero, and R. B. Caldwell Vascular Endothelial Growth Factor Signals Endothelial Cell Production of Nitric Oxide and Prostacyclin through Flk-1/KDR Activation of c-Src J. Biol. Chem., August 27, 1999; 274(35): 25130 - 25135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. SCALIA, G. BOOTH, and D. J. LEFER Vascular endothelial growth factor attenuates leukocyte–endothelium interaction during acute endothelial dysfunction: essential role of endothelium-derived nitric oxide FASEB J, June 1, 1999; 13(9): 1039 - 1046. [Abstract] [Full Text]
|
|
|
|
|
|
T. Murohara, B. Witzenbichler, I. Spyridopoulos, T. Asahara, B. Ding, A. Sullivan, D. W. Losordo, and J. M. Isner Role of Endothelial Nitric Oxide Synthase in Endothelial Cell Migration Arterioscler Thromb Vasc Biol, May 1, 1999; 19(5): 1156 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Cunningham, T. M. Tran, M. P. Arrate, R. Bjercke, and T. A. Brock KDR activation is crucial for VEGF165-mediated Ca2+ mobilization in human umbilical vein endothelial cells Am J Physiol Cell Physiol, January 1, 1999; 276(1): C176 - C181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-G. Shyu, O. Manor, M. Magner, G. D. Yancopoulos, and J. M. Isner Direct Intramuscular Injection of Plasmid DNA Encoding Angiopoietin-1 but not Angiopoietin-2 Augments Revascularization in the Rabbit Ischemic Hindlimb Circulation, November 10, 1998; 98(19): 2081 - 2087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-Q. Shen, D. Y. Lee, H.-P. Gerber, B. A. Keyt, N. Ferrara, and T. F. Zioncheck Homologous Up-regulation of KDR/Flk-1 Receptor Expression by Vascular Endothelial Growth Factor in Vitro J. Biol. Chem., November 6, 1998; 273(45): 29979 - 29985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Metais, J. Li, J. Li, M. Simons, and F. W. Sellke Effects of coronary artery disease on expression and microvascular response to VEGF Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1411 - H1418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Witzenbichler, T. Asahara, T. Murohara, M. Silver, I. Spyridopoulos, M. Magner, N. Principe, M. Kearney, J.-S. Hu, and J. M. Isner Vascular Endothelial Growth Factor-C (VEGF-C/VEGF-2) Promotes Angiogenesis in the Setting of Tissue Ischemia Am. J. Pathol., August 1, 1998; 153(2): 381 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Nicosia What Is the Role of Vascular Endothelial Growth Factor-Related Molecules in Tumor Angiogenesis? Am. J. Pathol., July 1, 1998; 153(1): 11 - 16. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Matsuura, W. Yamochi, K.-i. Hirata, S. Kawashima, and M. Yokoyama Stimulatory Interaction Between Vascular Endothelial Growth Factor and Endothelin-1 on Each Gene Expression Hypertension, July 1, 1998; 32(1): 89 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hippenstiel, M. Krull, A. Ikemann, W. Risau, M. Clauss, and N. Suttorp VEGF induces hyperpermeability by a direct action on endothelial cells Am J Physiol Lung Cell Mol Physiol, May 1, 1998; 274(5): L678 - L684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Folkman Therapeutic Angiogenesis in Ischemic Limbs Circulation, March 31, 1998; 97(12): 1108 - 1110. [Full Text] [PDF]
|
|
|
|
|
|
J. D. Hood, C. J. Meininger, M. Ziche, and H. J. Granger VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H1054 - H1058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Parenti, L. Morbidelli, X.-L. Cui, J. G. Douglas, J. D. Hood, H. J. Granger, F. Ledda, and M. Ziche Nitric Oxide Is an Upstream Signal of Vascular Endothelial Growth Factor-induced Extracellular Signal-regulated Kinase1/2 Activation in Postcapillary Endothelium J. Biol. Chem., February 13, 1998; 273(7): 4220 - 4226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Murohara, J. R. Horowitz, M. Silver, Y. Tsurumi, D. Chen, A. Sullivan, and J. M. Isner Vascular Endothelial Growth Factor/Vascular Permeability Factor Enhances Vascular Permeability Via Nitric Oxide and Prostacyclin Circulation, January 13, 1998; 97(1): 99 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Noiri, E. Lee, J. Testa, J. Quigley, D. Colflesh, C. R. Keese, I. Giaever, and M. S. Goligorsky Podokinesis in endothelial cell migration: role of nitric oxide Am J Physiol Cell Physiol, January 1, 1998; 274(1): C236 - C244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Horowitz, A. Rivard, R. van der Zee, M. Hariawala, D. D. Sheriff, D. D. Esakof, G. M. Chaudhry, J. F. Symes, and J. M. Isner Vascular Endothelial Growth Factor/Vascular Permeability Factor Produces Nitric Oxide–Dependent Hypotension : Evidence for a Maintenance Role in Quiescent Adult Endothelium Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2793 - 2800. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Hayashi, K. Abe, H. Suzuki, and Y. Itoyama Rapid Induction of Vascular Endothelial Growth Factor Gene Expression After Transient Middle Cerebral Artery Occlusion in Rats Stroke, October 1, 1997; 28(10): 2039 - 2044. [Abstract] [Full Text]
|
|
|
|
|
|
C. R. White, J. Shelton, S.-J. Chen, V. Darley-Usmar, L. Allen, C. Nabors, P. W. Sanders, Y.-F. Chen, and S. Oparil Estrogen Restores Endothelial Cell Function in an Experimental Model of Vascular Injury Circulation, September 2, 1997; 96(5): 1624 - 1630. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. O SCHLINGEMANN and V. W M VAN HINSBERGH Role of vascular permeability factor/vascular endothelial growth factor in eye disease Br J Ophthalmol, June 1, 1997; 81(6): 501 - 512. [Full Text] [PDF]
|
|
|
|
|
|
R. van der Zee, T. Murohara, Z. Luo, F. Zollmann, J. Passeri, C. Lekutat, and J. M. Isner Vascular Endothelial Growth Factor/Vascular Permeability Factor Augments Nitric Oxide Release From Quiescent Rabbit and Human Vascular Endothelium Circulation, February 18, 1997; 95(4): 1030 - 1037. [Abstract] [Full Text]
|
|
|
|
|
|
E. Van Belle, F. O. Tio, T. Couffinhal, L. Maillard, J. Passeri, and J. M. Isner Stent Endothelialization: Time Course, Impact of Local Catheter Delivery, Feasibility of Recombinant Protein Administration, and Response to Cytokine Expedition Circulation, January 21, 1997; 95(2): 438 - 448. [Abstract] [Full Text]
|
|
|
|
|
|
M. W. Majesky A Little VEGF Goes a Long Way: Therapeutic Angiogenesis by Direct Injection of Vascular Endothelial Growth Factor–Encoding Plasmid DNA Circulation, December 15, 1996; 94(12): 3062 - 3064. [Full Text]
|
|
|
|
|
|
Y. Tsurumi, S. Takeshita, D. Chen, M. Kearney, S. T. Rossow, J. Passeri, J. R. Horowitz, J. F. Symes, and J. M. Isner Direct Intramuscular Gene Transfer of Naked DNA Encoding Vascular Endothelial Growth Factor Augments Collateral Development and Tissue Perfusion Circulation, December 15, 1996; 94(12): 3281 - 3290. [Abstract] [Full Text]
|
|
|
|
|
|
T. Asahara, D. Chen, Y. Tsurumi, M. Kearney, S. Rossow, J. Passeri, J. F. Symes, and J. M. Isner Accelerated Restitution of Endothelial Integrity and Endothelium-Dependent Function After phVEGF165 Gene Transfer Circulation, December 15, 1996; 94(12): 3291 - 3302. [Abstract] [Full Text]
|
|
|
|
|
|
J. Waltenberger, U. Mayr, S. Pentz, and V. Hombach Functional Upregulation of the Vascular Endothelial Growth Factor Receptor KDR by Hypoxia Circulation, October 1, 1996; 94(7): 1647 - 1654. [Abstract] [Full Text]
|
|
|
|
|
|
D. F. Lazarous, M. Shou, M. Scheinowitz, E. Hodge, V. Thirumurti, A. N. Kitsiou, J. A. Stiber, A. D. Lobo, S. Hunsberger, E. Guetta, et al. Comparative Effects of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Coronary Collateral Development and the Arterial Response to Injury Circulation, September 1, 1996; 94(5): 1074 - 1082. [Abstract] [Full Text]
|
|
|
|
|
|
W. Casscells Growth Factor Therapies for Vascular Injury and Ischemia Circulation, June 1, 1995; 91(11): 2699 - 2702. [Full Text]
|
|
|
|
|
|
T. Asahara, C. Bauters, C. Pastore, M. Kearney, S. Rossow, S. Bunting, N. Ferrara, J. F. Symes, and J. M. Isner Local Delivery of Vascular Endothelial Growth Factor Accelerates Reendothelialization and Attenuates Intimal Hyperplasia in Balloon-Injured Rat Carotid Artery Circulation, June 1, 1995; 91(11): 2793 - 2801. [Abstract] [Full Text]
|
|
|
|
|
|
J. Igarashi and T. Michel Agonist-modulated Targeting of the EDG-1 Receptor to Plasmalemmal Caveolae. eNOS ACTIVATION BY SPHINGOSINE 1-PHOSPHATE AND THE ROLE OF CAVEOLIN-1 IN SPHINGOLIPID SIGNAL TRANSDUCTION J. Biol. Chem., October 6, 2000; 275(41): 32363 - 32370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Igarashi, S. G. Bernier, and T. Michel Sphingosine 1-Phosphate and Activation of Endothelial Nitric-oxide Synthase. DIFFERENTIAL REGULATION OF Akt AND MAP KINASE PATHWAYS BY EDG AND BRADYKININ RECEPTORS IN VASCULAR ENDOTHELIAL CELLS J. Biol. Chem., April 6, 2001; 276(15): 12420 - 12426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Igarashi and T. Michel Sphingosine 1-Phosphate and Isoform-specific Activation of Phosphoinositide 3-Kinase beta . EVIDENCE FOR DIVERGENCE AND CONVERGENCE OF RECEPTOR-REGULATED ENDOTHELIAL NITRIC-OXIDE SYNTHASE SIGNALING PATHWAYS J. Biol. Chem., September 21, 2001; 276(39): 36281 - 36288. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
